5-09-2025, 01:24

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

Notified -
Globe Newswire5-09-2025, 01:24
20-06-2024, 21:46

Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
Globe Newswire20-06-2024, 21:46